Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

By M. Rodríguez-Oroz, M. Jahanshahi, P. Krack, I. Litvan, R. Macias, E. Bézard, Jose A. Obeso. Lancet Neurology, 2009

827 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/095d5e8c839f3fcdec446bacab3327d8d440ff06

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. Jose A. Obeso
2. Hagai Bergman
3. Stéphane Lehéricy
4. Peter Redgrave
5. Gianluca Baldassarre
6. Fred Henrik Hamker
7. Michael J Frank
8. Kevin N. Gurney

In Neurology

1. Jose A. Obeso
2. Hagai Bergman
3. Peter Redgrave
4. Shimon Edelman

Citations in the corpus

• Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease (2010, background): “Thus, dysfunction of basal ganglia sensorimotor circuits marks the initial stages of Parkinson's diseas”
• Health, USA Reviewed by: (2010, neutral): “Interestingly, not all PD related changes in connectivity are normalized by l-DOPA (Palmer et al., 2009), consistent with noradrenergic and serotonergic contributions to cognitive dysfunction in PD (Marsh et al., 2009; Rodriguez-Oroz et al., 2009).”
• Parkinson's disease: genetics and pathogenesis. (2011, background): “As detailed below, PD motor manifestations are attributable to dopaminergic cell loss within the substantia nigra (SN) pars compacta and resultant dysfunction of the basal ganglia, a cluster of deep nuclei that participate in the initiation and execution of movements (Figure 1) (8).”